Who We Are
The Janssen Pharmaceutical Companies of Johnson & Johnson is now J&J Innovative Medicine. We’ve always been part of Johnson & Johnson and now our identity better conveys that. Our new brand truly reflects the best of who we are and what we do to lead where medicine is going.
Patients inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science and compassion, we confidently address some of the most complex diseases of our time and unlock the potential medicines of tomorrow.
Our diverse portfolio spans multiple therapeutic areas — Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.
We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way.
Leading Where Medicine Is Going
Stay Updated
Follow us in the UK:
Inspired by Patients
We never lose sight of the people we serve, or the possibilities science provides. Continued listening and learning fuel the development and delivery of transformational medicines for the future.
We understand the impact of living with illness. That’s why we connect with patient groups, health experts and governments to improve how patients access and experience our innovations. We work tirelessly to deliver therapies that can change and help save lives.
Transforming the Future of Health
We innovate with purpose to lead where medicine is going. Innovation requires thinking differently so we continue to reimagine the entire research, development and delivery process.
Cutting-edge technologies and expert insight help us understand and address the serious health problems of today and unlock the potential medicines of tomorrow. We pursue new pathways, collaborate closely with healthcare professionals, and decipher data to help people live fuller lives.
Commitment to Access
Medicines can only help if people can get them. Every step of our journey means nothing if our medicine does not reach its final destination. We help navigate increasingly complex healthcare systems and continue to work to enable patient access to transformational medical innovation now and in the future.
What’s Next?
We’re excited to be launching our full re-branded website in the coming months! Come back soon to visit our new site with improved user experience.
CP-447055 | April 2024